Skip to content
Open access · CC-BY via OpenAlex

Alteration of Aging‐Dependent Micro<scp>RNA</scp>s in Idiopathic Pulmonary Fibrosis

Richard Seonghun Nho

Drug Development Research · 2015 · ▲ 28 citations

Abstract

Preclinical Research Idiopathic Pulmonary Fibrosis (IPF) is the most severe fibrotic lung disease and characterized by the accumulation of (myo)fibroblasts and collagen within the alveolar wall resulting in obliteration of the gas-exchange surface. Although the detailed pathogenesis is not understood, recent studies have found that several microRNAs (miRNAs) are associated with the progression of lung diseases including IPF. IPF is a fibrotic disease and, most frequently found in an aged population. In this review, the functional roles of miRNAs that are deregulated in IPF progression are discussed together with how aging affects the miRNA signature, altering the fibroblast phenotype and promoting lung fibrosis. Finally, the possibility of targeting miRNAs as a therapeutic approach for the treatment of IPF is discussed.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1002/ddr.21272
Canonical
link ↗
Fetched
2026-06-10 MST

Cite this

APA
Nho, R.S. (2015). Alteration of Aging‐Dependent Micro<scp>RNA</scp>s in Idiopathic Pulmonary Fibrosis. <em>Drug Development Research</em>. https://doi.org/10.1002/ddr.21272
Vancouver
Nho RS. Alteration of Aging‐Dependent Micro<scp>RNA</scp>s in Idiopathic Pulmonary Fibrosis. Drug Development Research. 2015. doi:10.1002/ddr.21272.
BibTeX
@article{richard2015Altera, title = {Alteration of Aging‐Dependent Micro<scp>RNA</scp>s in Idiopathic Pulmonary Fibrosis}, author = {Richard Seonghun Nho}, journal = {Drug Development Research}, year = {2015}, doi = {10.1002/ddr.21272}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings